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that are poised to release TNF-α
Shivajanani Sivakumaran∗1,2, Stephen Henderson∗2,3, Sophie Ward1,2,
Pedro Santos E. Sousa1,2, Teresa Manzo1,2, Lei Zhang1,2,
Thomas Conlan1,2, Terry K. Means4, Maud D’Aveni5, Olivier Hermine5,
Marie-The´re`se Rubio5, Ronjon Chakraverty∗∗1,2 and Clare L. Bennett∗∗1,2
1 Institute for Immunity and Transplantation, University College London, London, UK
2 Cancer Institute, University College London, London, UK
3 Bill Lyons Informatics Centre, University College London, London, UK
4 MGH Center for Immunology and Inflammatory Diseases, Harvard Medical School, Boston,
MA, USA
5 CNRS UMR 8147, Universite´ Paris Descartes, Faculte´ de Me´decine, Hoˆpital Necker, Paris,
France
Dendritic cells (DCs) play a vital role in innate and adaptive immunities. Inducible deple-
tion of CD11c+ DCs engineered to express a high-affinity diphtheria toxin receptor has
been a powerful tool to dissect DC function in vivo. However, despite reports showing that
loss of DCs induces transient monocytosis, the monocyte population that emerges and
the potential impact of monocytes on studies of DC function have not been investigated.
We found that depletion of CD11c+ cells from CD11c.DTR mice induced the expansion of
a variant CD64+ Ly6C+ monocyte population in the spleen and blood that was distinct
from conventional monocytes. Expansion of CD64+ Ly6C+ monocytes was independent
of mobilization from the BM via CCR2 but required the cytokine, G-CSF. Indeed, this pop-
ulation was also expanded upon exposure to exogenous G-CSF in the absence of DC
depletion. CD64+ Ly6C+ monocytes were characterized by upregulation of innate signal-
ing apparatus despite the absence of inflammation, and an increased capacity to produce
TNF-α following LPS stimulation. Thus, depletion of CD11c+ cells induces expansion of a
unique CD64+ Ly6C+ monocyte population poised to synthesize TNF-α. This finding will
require consideration in experiments using depletion strategies to test the role of CD11c+
DCs in immunity.
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Introduction
Dendritic cells (DCs) play a vital role in the activation and control
of cellular immunity. Much of our understanding of the require-
ment for DCs in regulating immunity has come from in vivomodels
of DC depletion in which different DC populations are engineered
to express a high-affinity diphtheria toxin (DT) receptor (DTR),
and can be inducibly and transiently depleted in vivo upon injec-
tion of DT [1, 2]. Inducible cell ablation is a powerful tool to
understand the role of a population of cells in vivo. However, it is
important that conclusions made regarding the physiological func-
tions of DCs following experimental depletion are also informed
by the impact that depletion has upon other cells in the immune
system.
Bone marrow (BM) derived circulating monocytes can be
divided into two populations, which are distinguished in mice by
expression of the glycoprotein Ly6C [3, 4]. “Nonclassical” Ly6Cneg
monocytes patrol endothelial vessels in the steady state and are
positioned to initiate a rapid response to infection [5]. “Classical”
or “inflammatory” Ly6C+ monocytes are released from the BM
via ligation of the chemokine receptor CCR2 [6–8]. The recent
identification of a common monocyte progenitor (cMoP) [9] and
lineage-tracing studies suggest a linear model in which cMoPs
give rise to Ly6C+ cells, which in turn seed the Ly6Cneg pool
[4, 10]. Activation of Ly6C+ monocytes results in the upregu-
lation of molecules associated with macrophage and DC func-
tion, and classical monocytes were long thought to function as
a pool of rapid reactionary cells capable of augmenting tissue
DCs and macrophages during inflammation [11–14]. However,
a number of recent studies have now demonstrated that Ly6C+
monocytes directly participate in innate and adaptive immunities
[15–18], and in the absence of infection, monocytes extravasate
into tissues and may contribute to immunosurveillance of periph-
eral antigens [19, 20]. Migration across the vascular endothelium
into tissue is sufficient to induce upregulation of molecules such
as the high-affinity IgG receptor FcγRI (CD64), and is linked to
transition toward a more activated and/or differentiated cell type
[20, 21].
The relative proportion of monocytes within the steady-state
mononuclear phagocyte system (MPS) is finely controlled by
serum levels of myeloid growth factors such as M-CSF, G-CSF,
and fms-like tyrosine kinase receptor-3 (ligand, Flt3(L)) [22]. This
balance has been exemplified in studies using the constitutive and
transient depletion of DCs. CD11c.DTA mice that are born lack-
ing DCs develop a myeloproliferative syndrome by 3 months of
age due to enhanced extramedullary hematopoiesis in the spleen
resulting in accumulation of CD115+ monocytes [23]. Homeosta-
sis of DC populations depends on signaling via Flt3, and removal
of DCs results in increased serum levels of Flt3(L) [23–25]. The
increase in Flt3(L) drives myeloproliferation in DC-deficient ani-
mals, due to the direct stimulation of myeloid progenitors in
the spleen [23]. Similarly, transient loss of DCs from DC-specific
DTR mice also induces monocytosis [2, 23, 26–28]. However,
despite reports of enhanced numbers of monocytes in DC-depleted
mice the immune characteristics of these cells have not been
investigated.
In this study, we find that transient depletion of CD11c+ cells
from CD11c.DTR mice results in the CCR2-independent, G-CSF-
dependent expansion of a novel CD64+ Ly6C+ monocyte pop-
ulation in the spleen that is transcriptionally distinct from both
Ly6C+ and Ly6Cneg monocytes. This variant monocyte population
is poised to release TNF-α on stimulation with LPS, and has the
potential to mediate inflammatory immunity in the absence of
DCs.
Results
Depletion of CD11c+ cells leads to expansion of a
distinct population of CD64+ Ly6C+ monocytes
To investigate the effect of depletion of CD11c+ DCs on the
MPS, we injected CD11c.DTR/EGFP mice with a single dose
of DT or PBS, and analyzed myeloid cells in the spleen 48 h
later. Supporting Information Figure 1 shows that CD11chigh GFP+
DCs are efficiently ablated from the spleen in this model, along
with CD11b+F4/80+Ly6Clow macrophages as has been previously
reported [28, 29]. Other nonmyeloid immune populations were
not affected (Supporting Information Fig. 1C). Analysis of spleno-
cytes from DT-treated recipients demonstrated that depletion of
CD11c+ cells resulted in the expansion of two populations of gran-
ular side scatter (SSC)int to high CD11b+ myeloid cells, in accord
with published data [26, 30, 31], that differentially expressed
Ly6C (Fig. 1A). Further, flow cytometric analyzes defined SSCint
cells as Ly6ChighCD115high classical monocyte-like cells (referred
to as Ly6C+ monocytes). The second SSChigh population was des-
ignated CD11b+Ly6C+CD115int neutrophils, which were further
defined by expression of Ly6G (Fig. 1A and B). Staining with Ly6G
also highlighted the presence of an uncharacterized population of
Ly6Gneg Ly6Cint cells in DT-treated mice (Fig. 1A). Kinetic ana-
lyzes demonstrated that the increase in splenic Ly6C+ monocytes
peaked 2 days after the injection of DT and decreased by day 4
(Fig. 1C). We also observed a concurrent peak in the number of
splenic neutrophils (Supporting Information Fig. 2A). However,
in the blood and BM, monocytes continued to expand over the
course of the experiment (Fig. 1D). By contrast, the frequency of
neutrophils rapidly increased in the blood and BM 1 day after
treatment. This increase was not matched by a change in the
numbers of BM neutrophils, possibly due to small differences in
the frequency of BM neutrophils in the context of other changing
cell populations (Supporting Information Fig. 2B). The increases
in splenic monocytes and neutrophils were also confirmed by ana-
lyzing expansion of CD11b+Ly6C+ and Ly6G+ cells, respectively,
48 h after the injection of PBS or DT (Supporting Information
Fig. 2C). To confirm that expansion of Ly6C+ cells was dependent
on depletion of CD11c-expressing cells, we injected DT into both
wild-type (WT) C57BL/6 mice and Langerin.DTR mice, the lat-
ter another DTR expressing strain, and analyzed the expansion of
C© 2015 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
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Figure 1. Expansion of Ly6C+ monocytes following depletion of CD11c+ cells. CD11c.DTR mice were injected with PBS or DT and analyzed
48 h later. (A) Representative dot plots showing the expansion of monocytes (blue and orange) and neutrophils (green) in the spleens of PBS-
and DT-injected CD11c.DTR mice. Dot plots are pregated on live single cells. Dot plots on the far right show expression of Ly6C and Ly6G by
CD11b+Ly6Chigh (blue and orange) and CD11b+Ly6Cint (green) gated cells overlaid on live cells. (B) Representative dot plots showing expression
of CD115 and Ly6C by gated CD11b+Ly6Chigh (blue and orange) or Ly6Cint (green) cells. Plots are representative of more than three independent
experiments. (C) Graphs show the percentage ± SEM (left) and number ± SEM (right) of CD11b+Ly6Chigh monocytes in the spleen of PBS-treated
(blue) and DTR-treated (orange) recipients at different times post injection of DT. Two-way ANOVA with multiple comparisons (*) PBS versus DT
on day 2 p < 0.0001. Data are pooled from multiple independent experiments: day 1 PBS/DT n = 6, day 2 PBS/DT n = 26/24, day 4 PBS/DT n = 6. (D)
Left: graph showing the frequency ± SEM of monocytes in the blood and BM of PBS-treated (blue triangles and squares) and DT-treated (orange
triangles and squares) recipients. Two-way ANOVAwith multiple comparisons (*) day 2 BM and blood p = 0.0016 and p = 0.0012, respectively, day 4
p < 0.0001 for both. Right: graph showing the number ± SEM of monocytes in the BM from the femurs and tibias of one back leg. Two-way ANOVA
with multiple comparisons (*) p = 0.0015 on day 4. Data are pooled from multiple independent experiments: days 1 and 4 PBS/DT n = 6, day 2 BM
PBS/DT n = 14/12, blood PBS/DT n = 12.
Ly6C+ cells in the spleen 48 h later. Ly6C+ cells did not expand in
the spleen or epidermis of either DT-treated WT or Langerin.DTR
mice (Supporting Information Fig. 2D). Together, these data
suggest that the loss of CD11c+ cells drives expansion of mono-
cytes and neutrophils in the spleen of CD11c.DTR mice. These
observations agree with other published studies that have reported
monocytosis and neutrophilia after depletion of DCs in other, more
specific, models of DC depletion [27, 28, 31, 32]. In particular,
depletion of DCs, but not macrophages, results in monocytosis
in zDC.DTR mice [27]. Therefore, together these studies strongly
suggest that the loss of DCs is sufficient to drive expansion of
myeloid cells in these mice.
To compare monocytes from PBS- or DT-injected mice, we ini-
tially examined the cells by microscopy. Ly6C+ monocytes in DT-
injected mice were more vacuolated than monocytes from PBS-
injected controls, suggesting that the depletion of DCs results in
the expansion of a more differentiated cell (Fig. 2A). Therefore,
we analyzed features associated with monocyte differentiation in
vivo. Figure 2B shows that Ly6C+ monocytes from DT-injected
mice were more granular (increased SSC) than cells from con-
trol mice. Both populations expressed low-to-negative levels of
CD11c, MHC II, and F4/80 as described for Ly6C+ monocytes
[33], although F4/80 was slightly increased on monocytes from
DT-treated mice compared with isotype controls. However, the
IgG receptor FcγRI (CD64) was expressed in both groups and the
level of expression was doubled on DT-Ly6C+ cells (Fig. 2C, mean
expression on PBS cells = 897.4 ± 59.38 (SEM) compared with
1805 ±108.8 on DT-Ly6C+ cells). Circulating Ly6C+ cells in the
blood of DT-injected mice also expressed higher levels of CD64
than PBS-treated controls (Fig. 2D), but these levels were lower
than on Ly6C+ monocytes in the spleen (Fig. 2E). Injection of DT
did not lead to an increase in tissue monocytes, which expressed
the highest levels of CD64 as previously reported (Supporting
Information Fig. 3) [20]. Collectively, our data demonstrate that
the depletion of DCs results in the accumulation of a distinct pop-
ulation of CD64+ Ly6C+ cells.
C© 2015 The Authors. European Journal of Immunology published by
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Figure 2. DT-Ly6C+ monocytes express
CD64. (A) Photomicrographs show
Giemsa-stained cytospins of sorted
CD11b+Ly6ChighCD115high cells from PBS-
and DT-treated mice, bars = 100 μM.
(B) Representative histograms (top)
and graph (bottom) showing SSC of
CD11b+Ly6ChighCD115high monocytes from
PBS-treated (white) or DT-treated (gray)
mice. Graph shows SSC ± SEM from
PBS-treated (n = 15) and DT-treated (n
= 13) mice. Data are pooled from four
independent experiments: PBS versus
DT p = 0.0186. (C) Top: representative
histograms showing expression of labeled
surface markers on CD11b+Ly6Chigh or
CD11b+Ly6ChighCD115high monocytes from
PBS-treated (white) and DT-treated (gray)
mice. Staining with the relevant isotype
control is shown by the thin line. Numbers
are the median fluorescence intensity
(MFI). Bottom: Graphs show the MFI ±
SEM for CD64, CD11c, MHC II, and F4/80
on monocytes gated as for the histograms
(n = 8 or 6 for F4/80 expression). Horizontal
lines mark the mean; data are pooled
from three independent experiments:
CD64 PBS versus DT p = 0.0002, CD11c p =
0.0014, MHC II p = 0.0070, F4/80 p = 0.0043.
(D) Left: representative dot plots showing
the frequency of gated live cells in the
blood of CD11c.DTR mice injected with DT
48 h earlier. Right: histograms showing
expression of CD64 by CD11b+Ly6Chigh
monocytes from PBS-treated (white) and
DT-treated (gray) mice. (E) Paired line
graphs showing the median fluorescent
intensity of CD64 on CD11b+Ly6Chigh
monocytes from the blood and spleens of
PBS- and DT-treated mice. Data are pooled
from three independent experiments, n =
8. Student’s paired t-test in both PBS- and
DT-treated animals, p < 0.0001. Statistical
analyses for other experiments were
carried out with a Student’s unpaired t-test
(+) or Mann–Whitney (*) as appropriate.
DC depletion drives expansion of a tran-
scriptionally distinct population of Ly6C+ monocytes
Ly6C+ MHC class II+ blood monocytes were recently iden-
tified that seed tissue monocyte populations in the steady
state [19]. These cells upregulate CD64 and follow extrava-
sation. Therefore, we examined the relationship between
DT-Ly6C+ monocytes and other splenic and tissue monocyte
populations in more detail. We sorted test and control cell
populations to high purity and compared their transcriptional
profiles by hybridization to an Affymetrix microarray. Specif-
ically, we purified spleen lineagenegCD11b+CD115highLy6Chigh
monocytes from DT- or PBS-injected CD11c.DTR mice,
spleen lineagenegCD11b+CD115highLy6Cneg monocytes, and BM
cMoPs (lineagenegCD117+CD115+CD135negLy6C+CD11bneg) [9].
All control populations were validated against publically available
Immgen datasets (http://www.immgen.org, see materials and
methods). Multidimensional scaling analysis, which offers a visual
representation of the proximity of the datasets, demonstrated that
DT-Ly6C+ monocytes were transcriptionally distinct from classi-
cal Ly6C+ and Ly6Cneg monocytes, and were more distant from
precursor cells than both these populations, suggesting the devel-
opment of a more differentiated cell type (Fig. 3A). To explore
the lineage relationship between PBS- and DT-Ly6C+ monocytes
further, we specifically analyzed the expression of a panel of genes
that encode transcriptional factors implicated in monocyte differ-
entiation [3, 9]. The heat map in Figure 3B shows the relative
expression of the panel of genes by macrophage/DC precursors
(MDPs), cMoPs, and Ly6C+ monocytes from PBS- and DT-treated
mice. These data demonstrate that DT-Ly6C+ monocytes express
transcription factors associated with monocyte differentiation at
higher levels than the other cell populations, reinforcing the con-
cept that the depletion of DCs drives the expansion of a highly
differentiated monocyte population.
DT-Ly6C+ cells were transcriptionally distinct from classical
splenic Ly6C+ monocytes and showed features linked to more
advanced differentiation, therefore, we next queried whether
they were instead more similar to tissue monocytes. Thus, we
C© 2015 The Authors. European Journal of Immunology published by
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Figure 3. DT-Ly6C+ monocytes are transcriptionally distinct from blood and tissue monocyte populations. CD11c.DTR mice were
injected with PBS or DT, and 48 h later splenic lineagenegCD11b+CD115highLy6Chigh monocytes were sorted to high purity and ana-
lyzed by hybridization to an Affymetrix microarray. We also sorted lineagenegCD11b+CD115highLy6Cneg monocytes and BM cMoPs
(lineagenegCD117+CD115+CD135negLy6C+CD11bneg) from C57BL/6 mice. (A) Multidimensional Scaling (MDS) comparing the transcriptional pro-
file of DT-Ly6C+ cells to other precursors and monocyte populations (Immgen MDP n = 3, UCL cMoP n = 3, UCL PBS Ly6C+ n = 4, and Immgen (PBS)
Ly6C+ n = 3, UCL Ly6Cneg n = 3, and Immgen n = 2). Each subset of cells was purified from at least two independent experiments and was derived
from individual mice, or pooled frommultiple mice. (B) Heat map comparing the relative expression of a panel of genes associated with monocyte
differentiation in the different cell populations. (C) PCA of gene expression by DT- and PBS-Ly6C+ monocytes in comparison to published data for
CD64+ migrating LN monocyte-derived DCs and dermal-cell subsets [20]. Approximately, 45 and 13% of the variance within the expression data is
orthogonal to PC1 and PC2, respectively (58% cumulative). (D) Heat map depicting the relative expression across all samples of the principal gene
signature (PC1, Supporting Information Fig. 2D) that separates the dermal P1–P5 group. DT-Ly6C+ n = 4, PBS-Ly6C+ n = 9 (Immgen, UCL), P1–P5
[20].
C© 2015 The Authors. European Journal of Immunology published by
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compared PBS- and DT-Ly6C+ cells with the CD24neg dermal
monocyte/macrophage populations and migrating LN CD64+
monocyte-derived DCs that can be distinguished on the basis
of surface expression of CD64 and MHC Class II (P1–P5) as
recently published by Tamoutounour et al. [20]. The principal
components analysis (PCA) shown in Figure 3C demonstrates
that extravasation of Ly6C+ monocytes, and differentiation into
tissue macrophages, results in the expression of a shared tran-
scriptional profile that was not expressed by either PBS-Ly6C+
or DT-Ly6C+ monocytes from the spleen. However, DT-Ly6C+
monocytes were clearly also distinct from PBS-Ly6C+ monocytes
according to both principal components 1 and 2. To focus more
closely on the differences between the cell types, we examined the
signatures that differentiate P1-P5 cells, again using PCA (Sup-
porting Information Fig. 4). Then, using the strongest signature of
difference within P1–P5 (the primary principal component PC1)
we defined a gene signature that best distinguishes P1/2 from
P3–P5. Using this signature, we plotted a heat map displaying
this signature across P1-P5 and DT-Ly6C+ monocytes (Fig. 3D).
The heat map shows that, despite increased expression of CD64,
DT-Ly6C+ monocytes cluster as a true variant of Ly6C+ mono-
cytes and both populations are transcriptionally distinct from cells
that have exited the vasculature and entered the tissues. How-
ever, consistent with our phenotypic analyzes, DT-Ly6C+ mono-
cytes are most similar to the P1/P2 cells of the dermal popula-
tions, that is, cells that have recently entered the skin. Of the
signature genes that differentiate P1/2 dermal monocytes, DT-
Ly6C+ cells have upregulated higher levels of expression of a
number of genes associated with cell migration and angiogenesis
(Gpr35, Itgb7, Met, Thbs1 [34–37]), but significantly downregu-
lated Cd33, which has been shown to repress monocyte-derived
pro-inflammatory cytokines [38]. Thus, our phenotypic and tran-
scriptional profiling data show that the depletion of DCs promotes
the expansion of differentiated monocytes that have upregulated
expression of CD64, but that remain transcriptionally distinct
from tissue monocytes, and are a true variant of splenic classical
Ly6C+ cells.
Expansion of Ly6C+ monocytes in DC-depleted mice
does not require signaling via CCR2
Classical Ly6C+ monocytes differentiate from committed precur-
sors in the BM before egress into the blood. Injection of DT
increased the frequency of Ly6C+ monocytes in the BM, whereas
the frequency ofmacrophage/DC precursors (MDPs) or cMoPswas
unchanged (Fig. 1 and Supporting Information Fig. 5A). To deter-
mine whether splenic Ly6C+ monocytes were directly recruited
from the BM, we initially analyzed the expansion of monocytes
in mice lacking CCR2. In these mice, monocytes cannot efficiently
leave the BM and Ccr2−/− animals have decreased numbers of
Ly6C+ monocytes in the circulation [7, 39]. Figure 4A shows
that the injection of DT into Ccr2−/−.CD11c.DTR mice resulted
in an expansion of splenic Ly6C+ monocytes to a similar extent
as Ccr2+/+.CD11c.DTR controls (Fig. 4A: Ccr2+/+.CD11c.DTR
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Figure 4. CCR2-independent expansion of DT-Ly6C+ monocytes in
vivo. (A) CD11c.DTR.Ccr2−/− mice or CD11c.DTR controls were injected
with PBS (n = 3–4) or DT (n = 2–4) and the expansion of monocytes ana-
lyzed in the spleen 48 h later. Graph shows the number of CD11b+Ly6C+
cells ± SEM, PBS versus DT in CD11c.DTR.Ccr2−/− mice p = 0.029. Data
are pooled from three independent experiments. (B) Schematic dia-
gram describing the competitive chimera experiments. (C) Left: rep-
resentative flow cytometry plots showing CD11b+Ly6C+ monocytes
in pregated bulk splenic CD45.2+ hematopoietic cells from PBS- or
DT-treated chimeras, and the percentage of WT (CD45.1+CD45.2+) or
Ccr2−/− (CD45.2+) cells in the monocyte gate. Right: graph shows the
frequency of WT or Ccr2−/− CD11b+Ly6C+ cells in the spleens of PBS- or
DT-treated chimeras; PBS-treated (n = 6) and DT-treated (n = 6) mice.
WT cells PBS versus DT p = 0.0260, Ccr2−/− cells p = 0.0411. Data are
pooled from two independent experiments. Statistical analyses were
carried out with a Mann–Whitney U test.
PBS- compared to DT-injected mice = 2.1-fold mean increase in
the frequency of CD11b+Ly6C+ monocytes; Ccr2−/−.CD11c.DTR
PBS- versus DT-treated = 2.7-fold increase), despite a lack of
circulating monocytes in the blood (Supporting Information Fig.
5B). To directly compare the contribution of cells that could or
could not signal via CCR2 to monocytosis in DT-treated mice, we
adopted a mixed chimera approach [39, 40]. CD11c.DTR.CD45.1
recipients were lethally irradiated and reconstituted with an equal
mixture of BM cells isolated from Ccr2−/−.CD11c.DTR.CD45.2 or
Ccr2+/+.CD11cDTR.CD45.1.2 donors. Eight weeks later, chimeras
were injected with DT, and expansion of Ccr2−/− (CD45.2)
C© 2015 The Authors. European Journal of Immunology published by
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versus WT (CD45.1.2) CD11b+Ly6C+ monocytes compared in
the blood and spleen (Fig. 4B). As expected, Ly6C+ monocytes
derived from WT BM preferentially accumulated in the spleen of
both PBS- and DT-treated chimeras, but with a significant con-
tribution from Ccr2−/− cells reflecting the mix of blood-derived
and extramedullary monocytes at this site [41]. Figure 4C shows
that DT treatment of mixed chimeras induced expansion of both
WT and Ccr2−/− Ly6C+ monocytes in the spleen (2.9-fold increase
in WT cells on injection of DT compared with 1.9-fold increase in
Ccr2−/− cells). Together, these data show that the depletion of DCs
results in the CCR2-independent expansion of some Ly6C+ mono-
cytes in the spleen, suggesting that these cells are not recruited
from the BM.
Depletion of DC results in the G-CSF-dependent
expansion of Ly6C+ monocytes
It has been previously reported that the depletion of DCs results
in increased serum levels of G-CSF [26, 31]. To test whether G-
CSF was required for the expansion of monocytes in DC-depleted
mice, we injected CD11c.DTR mice with αG-CSF neutralizing anti-
bodies prior to injection of PBS or DT. Figure 5A and B demon-
strates that endogenous G-CSF was required for the expansion of
DT-Ly6C+ monocytes and Ly6G+ neutrophils in the spleen of DC-
depleted mice. Consistent with the hypothesis that an increase in
serum growth factors promotes the expansion of splenic mono-
cytes in DC-depleted animals [23], subcutaneous treatment of
non-DC-depleted WT mice with exogenous G-CSF also mobilized
splenic monocytes and neutrophils but did not lead to an increase
in the numbers of these cells in the BM (Fig. 5C; number of
CD11b+Ly6ChighLy6Gneg monocytes in the BM of PBS-treated mice
= 1.28 × 106 ± 0.1376 × 106 (SEM) compared with 0.89 × 106
± 0.09712 × 106 in G-CSF-treated mice, n = 8 mice per group in
two independent experiments). Ly6Chigh monocytes isolated from
the spleens of G-CSF-treated mice were transcriptionally indistin-
guishable from DT-Ly6C+ monocytes, when comparing a panel of
genes with the topmost significant expression differences between
PBS- and DT-Ly6C+ cells (Fig. 5D).
It has been recently shown that murine neutrophils can trans-
differentiate into monocytes in vivo [42, 43]. Therefore, we
questioned whether DT-Ly6C+ monocytes were differentiating
from the enlarged neutrophil population in DC-depleted mice.
To address this question, we analyzed the expression profile of
a panel of signature neutrophil- and monocyte-associated genes
in DT-Ly6C+ monocytes [43]. The heat map in Figure 5E shows
that DT-Ly6C+ cells expressed a gene signature consistent with
monocytic cells (e.g.,mafB, csf1r), and did not express neutrophil-
associated genes (e.g., gfi1). Despite the requirement for G-CSF
shown in Figure 5A, these analyses revealed that DT-Ly6C+
monocytes expressed relatively lower levels of the G-CSF recep-
tor (csfr3) than PBS-Ly6C+ cells. However, it has been previ-
ously shown that the G-CSF receptor is not required for G-CSF-
dependent recruitment of neutrophils from the BM, suggesting
indirect actions of G-CSF on target cells [44]. Together with
published data, these results suggest that increases in serum G-
CSF are sufficient to drive the expansion of Ly6C+ monocytes in
DC-depleted mice [26].
Depletion of DC results in the accumulation Ly6C+
monocytes poised for innate immune activation
The effector function of Ly6C+ monocytes induced in the absence
of DCs is likely to depend on the immune environment encoun-
tered at the time of expansion. Therefore, to understand the envi-
ronmental cues to which DT-Ly6C+ monocytes might respond,
we performed a gene set enrichment analysis with curated gene
sets to compare the pathways of differentially expressed genes
in monocytes from control or DC-depleted mice. DT-Ly6C+ mono-
cytes were enriched for genes involved in TLR and innate signaling
pathways compared with control cells, with several overlapping
gene sets. The two highest-ranking pathways according to the nor-
malized enrichment score are shown in Figure 6A. Figure 6B lists
the genes that contribute to the leading-edge subset of the two
pathways. In addition to genes specific for the response to LPS
and TLR signaling pathways (tlr genes, Ly86, CD180, Peli), DT-
Ly6C+ monocytes were also enriched for genes encoding proteins
required for the production of cytokines involved in innate pro-
inflammatory immune responses (irf genes, Ikbk, Nfkb2, Zbp1).
Therefore, we hypothesized that Ly6C+ monocytes from DC-
depleted mice would produce more inflammatory cytokines in
response to LPS, than control cells. To test this hypothesis, we ana-
lyzed the production of several cytokines by sorted Ly6C+ mono-
cytes from DC-depleted and DC-replete mice. Figure 6B shows
that DT-Ly6C+ monocytes produced significantly more TNF-α than
classical splenic Ly6C+ monocytes, while no significant differences
were observed for the other cytokines tested. Together, these data
support a model in which the depletion of DC leads to the accumu-
lation of a differentiated population of monocytes that are poised
for innate immune activation.
Discussion
Over the last decade, the CD11c.DTR mice and other DC deple-
tion models have provided a powerful tool to understand DC
function [1, 2, 45], but the consequences of loss of DCs on
other cells of the MPS have not been fully appreciated. In this
study, we have characterized the splenic monocyte population
that expands after the depletion of DCs from CD11c.DTR mice.
We have shown that the loss of CD11c+ cells drives the accu-
mulation of a variant population of CD64+Ly6C+ monocytes
that upregulates the apparatus used for innate immune and TLR
signaling.
Classical monocytes express high levels of Ly6C, and low levels
of CD64 and MHC class II in the blood [19, 33]. Activation and/or
extravasation into tissues results in the downregulation of Ly6C
and upregulation of CD64 and MHC class II, resulting in a “cas-
cade” of cells when these antigens are plotted on flow cytometric
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Figure 5. DC-dependent monocytosis requires
G-CSF. (A) CD11c.DTR mice were injected with
αG-CSF or control prior to the depletion of DCs
and analyzed 48 h later. Representative dot plots
showing the frequency of gated monocytes or
neutrophils in the spleen. Dot plots are pregated
on live single cells. (B) Graphs showing the per-
centage ± SEM of CD11b+Ly6Chigh monocytes
(top) or CD11b+Ly6G+ neutrophils (bottom) in
the spleen and blood of PBS-treated (n = 8), DT
+ control-treated (n = 9), and DT + αG-CSF-
treated groups (n = 12). Splenic monocytes PBS
versus DT p < 0.001, DT versus DT + αG-CSF
p = 0.033, PBS versus DT + αG-CSF p = 0.132;
splenic neutrophils PBS versus DT p = 0.028,
DT versus DT + αG-CSF p < 0.001, PBS versus
DT + αG-CSF p = 0.296; ns = not significant.
Data are pooled from three independent exper-
iments. (C) WT mice were injected s.c. with PBS
(0) or G-CSF (+) for 5 days. Graphs show the num-
ber ± SEM of CD11b+Ly6C+ monocytes (left) and
CD11b+Ly6G+ neutrophils (right) in the spleens
of treated or control mice. Cells were gated
from plots equivalent to those shown in Fig-
ure 1A. Monocytes and neutrophils PBS versus
G-CSF p < 0.0001. Statistical analyses were car-
ried out with aMann–Whitney U test. (D) Splenic
lineagenegCD11b+Ly6C+ monocytes were puri-
fied frommice treated with G-CSF (G-CSF-Ly6C+
cells). A representative panel of the 12 most
significant expression differences between PBS
Ly6C+ and DT Ly6C+ monocytes was elected
using the limmaprocedure. The heatmap shows
that the G-CSF Ly6C+ samples show a strongly
similar expression pattern to DT Ly6C+ accord-
ing to these genes: PBS-Ly6C+ n = 9, DT-Ly6C+
n = 4, G-CSF-Ly6C+ n = 3. (E) Heat map show-
ing differential Z-scored expression of a neu-
trophil/monocyte gene panel in the three sets
of samples: Neu (n = 4), PBS Ly6C+ (n = 9), and
DT Ly6C+ (n = 4). The gene expression profile
for neutrophils was obtained from the Immgen
database.
dot plots [20, 33, 40, 46]. This phenotypic transition as monocytes
egress out of the vasculature is associated with the expression of
a distinct tissue-dependent transcriptional signature (Fig. 2) [20].
Here, we have identified a population of splenic monocytes that
spontaneously express CD64, but that do not cluster with der-
mal monocytes in PCA. Therefore, the loss of DCs results in the
expansion of a variant Ly6C+ splenic monocyte. However, DT-
Ly6C+ cells also display characteristics associated with Ly6Cneg
monocytes—for example, the upregulation of the transcription
factor Nr4a1 [47], and expression of TLRs and other molecules
required for sensing of nucleic acids [5]. Our findings there-
fore demonstrate that the distinction between individual mono-
cyte populations may become blurred under conditions of acute
depletion of CD11c+ myeloid cells when the cellular composition
within the MPS is perturbed.
Recent publications have presented an emerging picture of con-
trol of homeostasis within the MPS by serum cytokines, notably
M-CSF. Removal of populations that bind these cytokines will
result in a decrease in the local concentration, which may impact
on the proliferation and survival of other myeloid populations
[10, 48]. DC populations act as a cellular sink for the growth
factors G-CSF and Flt3(L) [25, 26]. We have shown that G-CSF
is required for the expansion of splenic monocytes after the loss
of DCs, and that exogenous G-CSF is sufficient to induce a vari-
ant monopoiesis that is similar to that seen in DC-depleted mice.
Depletion of DCs also induces the expansion of splenic neutrophils
that are functionally important for the clearance of bacterial infec-
tions in these models [26, 30]. Jiao et al. recent reported that the
depletion of DCs from CD11c.DTR mice leads to neutrophilia in
the spleen and tissues by enhancing recruitment out of the BM
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Figure 6. DT-Ly6C+ monocytes express genes
associated with innate immune activation, and
secrete high levels of TNF-α upon stimulation
with LPS. (A) Gene set enrichment analysis was
used to identify differentially expressed path-
ways between DT-Ly6C+ cells and their most
closely related group: PBS-Ly6C+. The rank-
versus-ES score plots are shown for two rep-
resentative pathways upregulated in DT-Ly6C+
cells: blue=Reactome toll receptor cascade, red
= Reactome innate immune system. All path-
ways were significantly altered (false discovery
rate q-values< 0.01). (B) Table showing the core
enriched genes for the two pathways. (C) Puri-
fied CD11b+Ly6C+CD115high monocytes from
PBS-treated (n = 6) or DT-treated (n = 6) treated
mice were cultured overnight in medium with
orwithout LPS. Graphs show the amount± SEM
of cytokines secreted into the culture super-
natant. TNF-α PBS versus DT for LPS-treated
cells, p = 0.022. Data are pooled from two inde-
pendent experiments. Statistical analyses were
carried out with a Student’s unpaired t-test.
[31]. We have shown that monocytes and neutrophils expand
concurrently in the spleen after depletion of CD11c+ cells, and
both populations expand in response to G-CSF. It is not possible
however to infer causative mechanisms from these studies, and
future work is needed to determine whether G-CSF has a direct
or indirect effect on the expansion of monocytes in this model.
Our data further demonstrate that cells that do not express CCR2
expand in the spleens of DT-treated recipients. While we cannot
exclude a contribution from BM-derived cells, these data strongly
support a role for extramedullary expansion of monocytes or their
precursors. We did not detect differences in proliferation of Ly6C+
cells in the spleens of PBS- or DT-treated mice 48 h after treatment
(data not shown), however it is possible that we missed the point
of proliferation in our experiments. In addition, loss of CD11c+
cells may lead to local proliferation of splenic monocyte precur-
sors, including cMoPs [9]. Our findings are in line with previous
data showing that constitutive ablation of DCs resulted in monocy-
tosis due to a direct increase in hematopoiesis in the spleen [23].
Expression of CD11c is not restricted to DCs, and other cell
types may be depleted from CD11c.DTR mice [29, 49, 50]. We did
not observe changes in lymphoid cell populations in ourmodel, but
F4/80+ macrophages were absent from the spleen 48 h after injec-
tion of DT. Removal of macrophages will lead to increases in serum
M-CSF which could modulate monocyte populations [48]. How-
ever, the depletion of DCs results in the expansion of monocytes
and neutrophils in other mouse models in which DC populations
are specifically perturbed, strongly suggesting that monocytosis in
the CD11c.DTR mice is directly dependent on the ablation of DCs
[27, 31].
In conclusion we have shown that removal of CD11c+ cells
from the MPS in the steady state is sufficient to drive the rapid
transient expansion of a differentiated population of monocytes in
the spleen, suggesting a model in which the loss of DCs drives the
expansion of an effector monocyte population. Our kinetic analy-
ses suggest a transient peak in the accumulation of splenic mono-
cytes in DC-depleted mice. Therefore, there is a defined window
in DT-injected mice in which DT-Ly6C+ monocytes may mediate
responses to infectious or inflammatory challenge in the absence
of DCs. These cells may be sensitive to the environment in which
they emerge and, consistent with this concept, we have recently
demonstrated that monocytes mobilized by injection of G-CSF
produce iNOS, and become immunosuppressive, in a murine
model of GVH disease [51].
It has been recently demonstrated that expression of the high-
affinity DTR by DCs leads to hypocellularity in LN, but not in the
spleen of CD11c.DTRmice [32]. Together with our data, this study
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highlights the caution with which DC-depletion studies should
be interpreted, particularly in the context of infection and/or
inflammation.
Materials and methods
Mice
Animal protocols were approved by local institutional research
committees and in accordance with U.K. Home Office guidelines.
CD11c.DTR/GFP (B6.FVB-Tg(Itgax-DTR/ EGFP)57Lan/J) were
used as both heterozygotes and homozygotes for the DTR/GFP
transgene [52]. Ccr2−/− mice were a kind gift from Frederic
Geissmann [39]. CD11c+ DCs were depleted by a single i.p. injec-
tion of 100 ng of DT (Sigma, UK) in PBS [52, 53]. Depletion of
DCs was confirmed in all experiments. To mobilize Ly6C+ mono-
cytes C57BL/6 mice were injected s.c. for 5 days with rhuman
G-CSF (200 μg/kg/day; Neupogen, Amgen, France) or PBS vehi-
cle. G-CSF was neutralized by i.p. injection of two doses of 50 μg
αG-CSF 24 h apart (Clone 67604, R&DSystemsU.K.) adapted from
published data [54]. Controls received either nonspecific IgG1 or
PBS. The second dose was given immediately prior to the injection
of PBS or DT.
Competitive chimeras
Ten-week-old C57BL/6 mice received 11Gy X-ray irradiation bef-
ore i.v. injection of a 1:1 mixture of CD11c.DTR.CD45.1.CD45.2
and CD11c.DTR.Ccr2−/−.CD45.2 BM cells (5 × 106 total cells).
Chimeric mice were used at 3 months post reconstitution.
Flow cytometry
Spleens were digested with Collagenase IV (Worthington Bio-
chemical Corporation). The following antibodies were used for
flow cytometric analysis, all from eBiosciences or BD-Biosciences:
FcBlock (clone 2.4G2), anti-CD11b (M1/70), anti-CD11c (HL3),
anti-Ly-6C (AL-21), anti-Ly-6G (1A8), anti-CD45.1 (A20), anti-
CD45.2 (104), anti-MHCII (M5/114.15.2), anti-CD115 (AFS98),
anti-CD64, anti-F4/80 (BM8), anti-CD135 (A2F10), anti-CD117
(2B8). FSC-W and a lineage dump gate were used in some experi-
ments to exclude irrelevant cells (anti-CD3 (145-2C11), anti-CD19
(1D3), anti-B220 (RA3-6B2), anti-NK-1.1 (PK136), and anti-
Ly-6G (1A8)). Samples were acquired using a BD LSR Fortessa
Cell Analyzer (BD Bioscience), and analyzed using FlowJo soft-
ware (Treestar).
Microscopy
Splenic CD11b+Ly6C+ cells were FACS-sorted and spun onto
slides using a Cytospin 2 Centrifuge (Shandon Instruments). The
cells were air-dried, fixed with methanol, and stained with Giemsa
(Sigma Aldrich). Images were acquired using a Leica DMD108
(Leica Microsystems) microscope.
Microarray analysis, normalization, and validation
Total RNA was extracted from sorted cells using the RNeasy
Microkit (Qiagen, UK) and hybridized on Affymetrix Mogene
2.0 arrays at the UCL Cancer Institute core facility. A detailed
description of the methods used is included in the Supporting
Information.
Luminex
Sorted monocytes were cultured for 12 h ± 100 ng/mL LPS
(Sigma-Aldrich) at 2.5 × 105 cells/mL in duplicate wells, and
the supernatant analyzed with the FIDIS system using Luminex
100 software (LuminexCorp) and Mouse cytokine 10-plex panel
(Life Technologies).
Statistical analysis
Data were analyzed using Graphpad Prism 6 and statistical
comparisons were made by using a two-tailed Student t-test for
parametric data and a two-tailed Mann–Whitney U test for non-
parametric data. The kinetic experiments were analyzed using
a two-way ANOVA with multiple comparisons at different time
points, and an adjusted p-value according to Sidak’s multiple-
comparison test.
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